Evidence map›Paper›PMID 32573398›Full record

ArticleHuman vaccines & immunotherapeutics2021

Control of vaccine preventable diseases in Australian infants: reviewing a decade of experience with DTPa-HBV-IPV/Hib vaccine.

Julianne Bayliss, Michael Nissen, Damita Prakash, Peter Richmond, Kyu-Bin Oh, Terry Nolan

Open access · hybridAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Human vaccines & immunotherapeutics, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.6field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 10 citations in OpenAlex.

  1. Trial
  2. Infant protection from invasiveHuman vaccines & immunotherapeutics · 2025
    Review
  3. Review
  4. Article
  5. Observational
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Julianne BaylissMedical Affairs, GSK , Melbourne, Australia.ORCID 0000-0003-3578-4952
Michael NissenScientific Affairs & Public Health, GSK , Singapore, Singapore.ORCID 0000-0003-1686-3313
Damita PrakashMedical Affairs, GSK , Melbourne, Australia.
Peter RichmondDivision of Paediatrics and Centre for Child Health Research, University of Western Australia, Wesfarmers Centre of Vaccines and Infectious Diseases, Telethon Kids Institute, Perth Children's Hospital , Perth, Australia.ORCID 0000-0001-7562-7228
Kyu-Bin OhMedical Affairs, GSK , Singapore, Singapore.
Terry NolanVaccine and Immunisation Research Group (Virgo), University of Melbourne, School of Population and Global Health and Murdoch Children's Research Institute , Melbourne, Australia.ORCID 0000-0001-6018-3863
GlaxoSmithKline (Australia) · AUThe Kids Research Institute Australia · AUThe University of Melbourne · AU

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The combined vaccine against diphtheria, tetanus, pertussis, hepatitis B, poliomyelitis, and

Indexed as

Haemophilus influenzae type bHaemophilus VaccinesVaccine-Preventable DiseasesAustraliaChildDiphtheria-Tetanus-Pertussis VaccineHepatitis B VaccinesHepatitis B virusHumansImmunization ScheduleInfantPoliovirus Vaccine, InactivatedVaccines, CombinedDiphtheria-Tetanus-Pertussis VaccineHaemophilus VaccinesHepatitis B VaccinesPoliovirus Vaccine, InactivatedVaccines, CombinedAustraliacombination vaccinescoverageDTPa-HBV-IPV/HibHaemophilus influenzae type bhepatitis Binfant vaccinationpertussissafety

Identifiers

PMID32573398
PMCPMC7872029
OpenAlexW3036531221

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.